公司資料
ThermoGenesis 股價、新聞與催化劑
- 股票代碼:
- THMO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (-99.00%)
收盤價
最後更新: 2026年8月4日
—
市值
股價為何變動
Current closing-price context is not available for THMO.
公司概覽
業務概覽
ThermoGenesis was a biotechnology company focused on cell processing, cell banking, and manufacturing systems for regenerative medicine. Its business sat at the intersection of tools, services, and cell-therapy enablement.
所在地與產業分類
ThermoGenesis was headquartered in the United States and listed on NASDAQ. It sat in biotechnology tools and cell-processing infrastructure.
商業模式特徵
The company depended on platform adoption, manufacturing workflow demand, and the ability to monetize cell-processing technology. Investors historically watched commercial traction and strategic changes.
生技產業定位
ThermoGenesis belongs in the cell-processing infrastructure layer of biotech. It is not a classic drug stock, but it supported the manufacturing ecosystem around regenerative medicine.
未來催化劑
- ThermoGenesis is largely a legacy and closeout story now, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a fresh growth name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。